Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The results showed that a single intravenous or subcutaneous dose of LAE102 demonstrated a favorable safety profile in healthy subjects
This breakthrough reflects Sanofis ongoing commitment to innovation in rare disease treatment and improving lives
"Mundialmente 64 milhes de pessoas vivem com insuficincia cardaca e at 2030 a previso de um aumento de mais de 50%
When levels are low, the condition of dwarfism can develop
The investment amount was 507.094 billion yuan, indicating a 31.8% year-on-year decrease
US$ 25.57
US$ 27.50
US$ 23.14
US$ 26.23
US$ 21.18
US$ 27.96
US$ 28.13
US$ 25.13
US$ 27.52
US$ 19.98
US$ 1629.50
Sold : Login>>
